secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cartesian Therapeutics, Inc. (RNAC)
CIK:        0001453687
Form:       8-K
Filed at:   2024-04-09T23:59:59+00:00
Accession:  0001453687-24-000055
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cartesian Therapeutics Series A Preferred automatically converts, resulting in 17.8M shares outstanding
--------------------------------------------------------------------------------

- Automatic conversion of Series A Non-Voting Convertible Preferred Stock occurred on April 8, 2024.
- After conversion, common stock outstanding totals 17,779,787 shares.
- No further Series A Preferred shares remain outstanding; previously approved by stockholders on March 27, 2024.
- Company also filed updated corporate slide presentation for investor conferences.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453687/000145368724000055/0001453687-24-000055-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453687/000145368724000055/rnac-20240408.htm
  HTML page:      https://secwatch.observer/filing/0001453687-24-000055

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer